SCHEMBL8487459

SCHEMBL8487459

Cc1nc(N[C@H]2CC[C@H](O)CC2)nc2c(Nc3ccc(F)c(Cl)c3)ncnc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 10/20 0.57
ERBB2 P04626 5/20 0.57
HPGD P15428 1/20 0.57
HTT P42858 1/20 0.57
CSNK2A1 P68400 1/20 0.48
CDK1 P06493 4/20 0.44
AURKA O14965 1/20 0.42
RPS6KB1 P23443 1/20 0.42
MAPT P10636 1/20 0.42
BCL6 P41182 1/20 0.42
KCNH2 Q12809 1/20 0.42
CDK2 P24941 2/20 0.41
CCNA2 P20248 1/20 0.41
CCNA1 P78396 1/20 0.41
KDR P35968 1/20 0.41
CHEK2 O96017 1/20 0.41
CSNK1D P48730 1/20 0.41
MAPKAPK2 P49137 1/20 0.41
CDK5 Q00535 1/20 0.41
MAPKAPK3 Q16644 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8487455 1.00 EGFR (0.57) EGFRERBB2HPGDHTTCSNK2A1
SCHEMBL8486781 0.89 EGFR (0.57) EGFRERBB2HPGDHTTCSNK2A1
SCHEMBL8488224 0.88 EGFR (0.74) EGFRERBB2HPGDHTTCSNK2A1
SCHEMBL8316770 0.84 EGFR (0.77) EGFRERBB2HPGDHTTCSNK2A1
SCHEMBL6997208 0.84 EGFR (0.77) EGFRERBB2HPGDHTTCSNK2A1
SCHEMBL6997215 0.84 EGFR (0.77) EGFRERBB2HPGDHTTCSNK2A1
SCHEMBL8487099 0.83 EGFR (0.54) EGFRERBB2HPGDHTTCSNK2A1
SCHEMBL8487101 0.83 EGFR (0.54) EGFRERBB2HPGDHTTCSNK2A1
SCHEMBL8485773 0.81 EGFR (0.73) EGFRERBB2HPGDHTTCSNK2A1
SCHEMBL8485770 0.81 EGFR (0.73) EGFRERBB2HPGDHTTCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977102-A INHIBITORY EFFECT ON SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES OR EPIDERMAL GROWTH FACTOR; ANTITUMOR,-CARCINOGENIC, -METASTASIS,-PROLIFERATION AGENTS AND -INFLAMMATORY AGENTS; PSORIASIS; ANGIOGENESIS INHIBITORS; IMMUNOLOGY; DR. KARL THOMAE GMBH (DE) 1999-11-02 US disclosed